Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2019-01-10 07:49:44
R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide
The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids ...
Read More2018-12-10 13:14:17
Unjela Kaleem joins global pharma association as Director of Communications
Geneva, 10 December 2018 – IFPMA, the global research-based biopharmaceutical industry association, is pleased to ...
Read More2018-12-05 12:00:49
R&D biopharmaceutical industry revamp ethical code to apply as base line of industry behavior worldwide
New R&D biopharmaceutical industry Code of Practice comes into effect on 1 January 2019. Changes ...
Read More2018-12-04 17:17:22
David A. Ricks Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company, takes over as ...
Read More2018-11-16 06:30:08
Pharma industry launches call for coalition of countries to pilot new incentives for antibiotic R&D
16 November, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) draws attention ...
Read More2018-11-13 09:35:59
The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders
The AMR Industry Alliance has made major strides in 2018 taking action across four different ...
Read More2018-10-29 10:25:29
The R&D biopharmaceutical industry supports the Astana Declaration and renewed political commitment towards the importance of primary health care
26 October 2018, Astana – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the ...
Read More
Latest Statement
2019-05-27 16:21:25
IFPMA Statement at WHA72 agenda item 11.7 Access to medicines and vaccines
IFPMA, supported by ICBA, share the goal of WHO and its Members to ensure appropriate access to affordable and quality-assured ...
Read More2019-05-25 16:45:55
IFPMA Statement at WHA72 agenda item 12.10 The public health implications of implementation of the Nagoya Protocol
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-05-24 18:16:31
IFPMA Statement at WHA72 12.1 agenda item Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-05-22 11:57:20
IFPMA Statement at WHA72 agenda item 1.5 Universal Health Coverage
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-04-01 14:41:22
IFPMA Statement at the 22nd WHO Expert Committee Meeting on the Selection and Use of Essential Medicines
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-03-21 10:20:39
Statement on influenza vaccine supply in the 2019-20 Northern Hemisphere season
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-02-06 10:17:10
EB 144 agenda item 5.5 Universal health coverage
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
Five questions to .... Kawaldip Sehmi
Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO) talks to IFPMA about why the Essential Medicines List is important for patients. What does the addition of new medicines on the 2019 EML update mean for patients? The inclusion of any medicine, including innovative and specialty medicines, on the World Health Organization’s Essential Medicines List (EML) is good news: it should increase patient...
Read More
Flu can cause up to 650,000 deaths a year globally
This blog was originally published on Health Awareness Value of Vaccines 2019 campaign on 27 June 2019. Influenza is a highly infectious disease that usually strikes during the winter season. Globally, it causes an estimated one billion cases of influenza, resulting in 290,000 to 650,000 deaths per year. A person can get the virus simply by being near an infected person that coughs, sneezes or...
Read More
Universal Health Coverage: Moving Together, Stronger Together
This blog was originally published on Health Policy Watch on 7 June 2019. The first-ever United Nations High-Level Meeting (UNHLM) on Universal Health Coverage (UHC), scheduled for 23 September 2019, will soon be upon us. The sense of urgency in preparing for this historic milestone in achieving global health progress was palpable during the World Health Assembly (WHA). There is no lack of often passionate...
Read MoreLatest Tweets
